AI Article Synopsis

  • Phenthoate is a widely used organophosphorus pesticide that can cause serious health issues when ingested, with limited research available on its effects, prompting a study in Sri Lanka.
  • In a study involving 292 patients who self-poisoned with phenthoate, 14.4% required intubation, with a notable case fatality rate of 6.5%, and deaths primarily occurred within the first 24 hours post-ingestion.
  • The study noted a brief increase in cholinesterase enzyme activity in some patients treated with pralidoxime chloride, but this increase was not maintained over time, indicating challenges in effectively treating phenthoate poisoning.

Article Abstract

Background: The clinical characteristics following self-poisoning with organophosphorus (OP) insecticides differs according to the insecticide ingested. Phenthoate is a dimethoxy WHO Hazard Class II OP pesticide with limited literature on its clinical characteristics and outcome. We aimed to better understand its clinical characteristics by studying patients with phenthoate self-poisoning in Sri Lanka.

Methods: We conducted a prospective cohort study of patients presenting with phenthoate self-poisoning to eight hospitals in Sri Lanka between 2002 and 2018. Clinical outcomes were recorded for each patient. Blood samples for measuring plasma phenthoate concentration, cholinesterase activity, and response to oximes were available for a very small number of patients recruited to a clinical trial.

Results: Two hundred and ninety-two patients who ingested agricultural phenthoate formulations were included in the study. Median time to admission was 3.9 (IQR 2.4 - 6.8) h. Forty-two (14.4%) patients were intubated, mostly (30/37, 81%) within 24 h of ingestion (median time to intubation 7.2 [IQR 2.6-20.9] h). Median duration of intubation was 74.8 (IQR 26.8-232.5) h; the longest duration in a survivor was 592 h. Nineteen died (case fatality 6.5%, 95% CI 4.0-10.0); median time to death was 37 (IQR 16 - 101.7) h. Median plasma phenthoate concentration in patients with samples ( = 81) was 135 (IQR 62.7-356.5) ng/mL (0.42 µmol/mL [0.2 to 1.1 µmol/mL]). Five of six patients receiving pralidoxime chloride 2 g showed an initial increase in AChE and BuChE activity that was not sustained despite an infusion of pralidoxime.

Conclusion: Phenthoate self-poisoning has a 6.5% case fatality rate. Most patients who experience respiratory failure undergo early intubation; most deaths occurred among those patients who were intubated less than 24 h after ingestion. There was a non-sustained increase in cholinesterase activity with pralidoxime, but further studies are required to analyse the extent to which oximes are clinically effective in phenthoate self-poisoning.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15563650.2021.1917596DOI Listing

Publication Analysis

Top Keywords

phenthoate self-poisoning
20
clinical characteristics
12
median time
12
patients
9
phenthoate
8
plasma phenthoate
8
phenthoate concentration
8
cholinesterase activity
8
patients intubated
8
24 h ingestion
8

Similar Publications

Self-poisoning with organophosphorus (OP) insecticides is an important means of global self-harm. The insecticides are formulated with solvents that may also contribute to toxicity. We set up a study to detect changes in osmolal and anion gaps following ingestion of OP insecticides.

View Article and Find Full Text PDF
Article Synopsis
  • Phenthoate is a widely used organophosphorus pesticide that can cause serious health issues when ingested, with limited research available on its effects, prompting a study in Sri Lanka.
  • In a study involving 292 patients who self-poisoned with phenthoate, 14.4% required intubation, with a notable case fatality rate of 6.5%, and deaths primarily occurred within the first 24 hours post-ingestion.
  • The study noted a brief increase in cholinesterase enzyme activity in some patients treated with pralidoxime chloride, but this increase was not maintained over time, indicating challenges in effectively treating phenthoate poisoning.
View Article and Find Full Text PDF

Efficacy of an organophosphorus hydrolase enzyme (OpdA) in human serum and minipig models of organophosphorus insecticide poisoning.

Clin Toxicol (Phila)

May 2020

CSIRO Biocatalysis & Synthetic Biology Team, Black Mountain Science and Innovation Park, Canberra, Australia.

Current therapeutic options for organophosphorus (OP) insecticide self-poisoning including atropine and oximes are inadequate and case fatality may exceed 20%. An OP hydrolase enzyme, OpdA, has been used for environmental cleansing of OP insecticides and prevented death in rat and non-human primate models of OP insecticide poisoning if given very quickly after exposure. We here tested OpdA's ability to break down OP insecticides in human serum and in clinically relevant minipig models of OP insecticide poisoning.

View Article and Find Full Text PDF

Background: Deliberate self-poisoning (DSP) using organophosphorus (OP) insecticides are a common clinical problem in Asia. OPs inhibit acetylcholine esterase (AChE), leading to over-activity of muscarinic and nicotinic cholinergic circuits. Intermediate syndrome (IMS) is mediated via prolonged nicotinic receptor stimulation at the neuromuscular junction and its onset is between 24-96 hours post ingestion.

View Article and Find Full Text PDF

Background/aims: Organophosphate poisoning has a high mortality rate. Recently, differences among organophosphorus insecticides in human self-poisoning were reported. This study investigated the prognostic risk factors and the mortality of different organophosphates following acute organophosphate poisoning.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!